BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Accellent Announces Sale of its Pittsburgh Facility


5/4/2012 8:40:24 AM

WILMINGTON, Mass. -- Accellent Inc. (“Accellent” or the “Company”), a wholly-owned subsidiary of Accellent Holdings Corp., has entered into an agreement to sell its facility located just outside of Pittsburgh in Houston, Pennsylvania (the “Facility”) to The Perryman Company (“Perryman”), also headquartered in Houston, Pennsylvania. Substantially all of the Facility’s employees will become employees of Perryman effective upon completion of the sale, which is expected to be completed during the second quarter of 2012.

Donald Spence, President and CEO of Accellent, stated "This sale allows Accellent to better focus on its core medical device markets and provides a great future for our employees in Pittsburgh. Perryman is an international company with existing relationships with many of the Facility’s customers."

"This acquisition is consistent with Perryman’s strategy to leverage our full integration position and continue to deliver value for our medical customers," added Frank Perryman, President and CEO of Perryman.

About Accellent

Accellent provides fully integrated outsourced manufacturing and engineering services to the medical device industry primarily in the cardiology, endoscopy and orthopaedic markets. Accellent has broad capabilities in precision component fabrication, finished device assembly, complete supply chain management capabilities and engineering services. These capabilities enhance customers’ speed to market and return on investment by enabling them to refocus internal resources more efficiently. For more information, please visit www.accellent.com.

About Perryman

The Perryman Company, founded in 1988, is headquartered in Houston, Pennsylvania. Company offices are located in Philadelphia, Los Angeles, London, Zurich, Tokyo and Xi’an. Perryman is an integrated titanium producer from melting of ingot to finished products. The company’s product portfolio includes ingot, bar, coil, fine wire, net shapes and hot rolled products. A titanium global leader, Perryman supplies and services customers in the aerospace, medical, consumer, industrial and recreation markets worldwide. For more information, please visit www.perrymanco.com.

Forward-Looking Statements

This press release includes “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended. All statements included herein, other than statements of historical fact, may constitute forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. Important factors that could cause actual results to differ materially from the Company’s expectations are disclosed in the risk factors contained in the Company’s Form 10-K for the year ended December 31, 2011 filed with the Securities an Exchange Commission on March 29, 2012. All forward looking statements are expressly qualified in their entirety by such risk factors.

Read more here: http://www.sunherald.com/2012/05/04/3925901/accellent-announces-sale-of-its.html#storylink=cpy



Read at BioSpace.com

Accellent
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES